How were Biocon’s Q3 numbers?
Answer
Answer
Answer
Biocon sales were 17.68% up at Rs.219.60 crore for Dec-21 quarter. revenues were up 18% at Rs.2,223 crore. Bio-similar revenues grew 27.6% to Rs.981cr, while generics grew 5% to Rs.607 crore revenues and research services segment grew 9.7% at Rs.641.4 crore.